Skip to content
Screener

IDEX IEX Health & Science Technologies — Cost of Sales

Other segment segments

Fluid & Metering Technologies
$156.5M+2.3%
Fire & Safety/Diversified Products
$102.5M-2.8%

Similar metrics at other companies

IR
IRPrecision and Science Technologies — Cost of Sales
$206M+9.2%
Enpro logo
NPOSealing Technologies — Cost of Sales
$103.3M+13.6%
Flotek Industries logo
FTKChemistry Technologies — Cost of Sales
$68.42M+63.9%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Cost of Sales
$327M+9.7%
Baxter International logo
BAXHealthcare Systems & Technologies — Cost of Sales
$390M+9.6%
Enpro logo
NPOAdvanced Surface Technologies — Cost of Sales
$70M+9.2%

Other financials

Income statement

See full
Revenue$920.6M+4.8%
Gross profit$426.8M+9.3%
Operating income$199.9M+7.6%
Net income$143.4M+12.2%
EPS (diluted)$1.93+13.5%

Balance sheet

See full
Cash & equivalents$621.3M+3.6%
Total debt$1.9B-3.7%
Total equity$4.0B-0.1%
Total assets$6.9B-0.6%

Cash flow

See full
Operating cash flow$200.0M-1.7%
CapEx$23.0M+55.4%
Free cash flow$177.0M-6.2%

Valuation

See full
Market cap$17.47B+45.3%
Enterprise value$18.71B+40.3%
P/E32.7×+7.0×
P/S4.8×+1.2×

Profitability

See full
Gross margin44.7%+0.8pp
Operating margin20.8%+0.9pp
Net margin14.5%+0.8pp
FCF margin17.9%+0.3pp

Returns & leverage

See full
Return on equity13.3%+1.1pp
Debt / equity0.5×0.0×
Current ratio3×+0.1×

Where this comes from

Reported directly by IDEX in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: IDEX’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:35 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000832101-26-000022
Line itemHSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$414.0$316.7$189.9$920.6—$920.6
Intersegment sales1.00.4—1.4(1.4)—
Net sales415.0317.1189.9922.0(1.4)920.6
Adjusted segment cost of sales(1)(235.7)(156.5)(102.5)(494.7)1.4(493.3)
Other segment expenses(2)(60.0)(50.3)(32.5)(142.8)
Segment Adjusted EBITDA$119.3$110.3$54.9$284.5

Item 1. Financial Statements

FAQ

What is IDEX's health & science technologies — cost of sales?
IDEX (IEX) reported health & science technologies — cost of sales of $235.7M in Q2 2026.
How has IDEX's health & science technologies — cost of sales changed year-over-year?
IDEX's health & science technologies — cost of sales increased by 8.6% year-over-year, from $217M to $235.7M.
What is the long-term trend for IDEX's health & science technologies — cost of sales?
Over 3 years (2022 to 2025), IDEX's health & science technologies — cost of sales has grown at a 6.2% compound annual growth rate (CAGR), from $738.9M to $885.5M.
What does health & science technologies — cost of sales mean?
Includes the direct costs attributable to the production of goods and services sold within the Health and Science Technologies segment. This encompasses raw materials, direct labor, and manufacturing overhead directly associated with the segment's output.

Ask your AI about IDEX's health & science technologies — cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude